These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36942408)

  • 1. Parasite and host kinases as targets for antimalarials.
    Ong HW; Adderley J; Tobin AB; Drewry DH; Doerig C
    Expert Opin Ther Targets; 2023 Feb; 27(2):151-169. PubMed ID: 36942408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manipulating Eryptosis of Human Red Blood Cells: A Novel Antimalarial Strategy?
    Boulet C; Doerig CD; Carvalho TG
    Front Cell Infect Microbiol; 2018; 8():419. PubMed ID: 30560094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parasite and Host Erythrocyte Kinomics of Plasmodium Infection.
    Adderley J; Williamson T; Doerig C
    Trends Parasitol; 2021 Jun; 37(6):508-524. PubMed ID: 33593681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tackling resistance: emerging antimalarials and new parasite targets in the era of elimination.
    Mathews ES; Odom John AR
    F1000Res; 2018; 7():. PubMed ID: 30135714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antimalarial resistome - finding new drug targets and their modes of action.
    Carolino K; Winzeler EA
    Curr Opin Microbiol; 2020 Oct; 57():49-55. PubMed ID: 32682267
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Arendse LB; Wyllie S; Chibale K; Gilbert IH
    ACS Infect Dis; 2021 Mar; 7(3):518-534. PubMed ID: 33590753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malaria: targeting parasite and host cell kinomes.
    Doerig C; Abdi A; Bland N; Eschenlauer S; Dorin-Semblat D; Fennell C; Halbert J; Holland Z; Nivez MP; Semblat JP; Sicard A; Reininger L
    Biochim Biophys Acta; 2010 Mar; 1804(3):604-12. PubMed ID: 19840874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Overview of Available Antimalarials: Discovery, Mode of Action and Drug Resistance.
    Tang YQ; Ye Q; Huang H; Zheng WY
    Curr Mol Med; 2020; 20(8):583-592. PubMed ID: 32031068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A New Thienopyrimidinone Chemotype Shows Multistage Activity against Plasmodium falciparum, Including Artemisinin-Resistant Parasites.
    Bosson-Vanga H; Primas N; Franetich JF; Lavazec C; Gomez L; Ashraf K; Tefit M; Soulard V; Dereuddre-Bosquet N; Le Grand R; Donnette M; Mustière R; Amanzougaghene N; Tajeri S; Suzanne P; Malzert-Fréon A; Rault S; Vanelle P; Hutter S; Cohen A; Snounou G; Roques P; Azas N; Lagardère P; Lisowski V; Masurier N; Nguyen M; Paloque L; Benoit-Vical F; Verhaeghe P; Mazier D
    Microbiol Spectr; 2021 Oct; 9(2):e0027421. PubMed ID: 34724729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting malaria protein kinases.
    Cassiano GC; Tavella TA; Nascimento MN; Rodrigues DA; Cravo PVL; Andrade CH; Costa FTM
    Adv Protein Chem Struct Biol; 2021; 124():225-274. PubMed ID: 33632466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bridging the Gap in Malaria Parasite Resistance, Current Interventions, and the Way Forward from in Silico Perspective: A Review.
    Kumi RO; Oti B; Abo-Dya NE; Alahmdi MI; Soliman MES
    Molecules; 2022 Nov; 27(22):. PubMed ID: 36432016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heme Detoxification in the Malaria Parasite: A Target for Antimalarial Drug Development.
    de Villiers KA; Egan TJ
    Acc Chem Res; 2021 Jun; 54(11):2649-2659. PubMed ID: 33982570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmodium berghei K13 Mutations Mediate
    Simwela NV; Stokes BH; Aghabi D; Bogyo M; Fidock DA; Waters AP
    mBio; 2020 Nov; 11(6):. PubMed ID: 33173001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined antimalarial therapy using artemisinin].
    Majori G
    Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting malaria parasite invasion of red blood cells as an antimalarial strategy.
    Burns AL; Dans MG; Balbin JM; de Koning-Ward TF; Gilson PR; Beeson JG; Boyle MJ; Wilson DW
    FEMS Microbiol Rev; 2019 May; 43(3):223-238. PubMed ID: 30753425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioprospecting for Novel Heat Shock Protein Modulators: The New Frontier for Antimalarial Drug Discovery?
    Anokwuru C; Makumire S; Shonhai A
    Adv Exp Med Biol; 2021; 1340():187-203. PubMed ID: 34569026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Another decade of antimalarial drug discovery: New targets, tools and molecules.
    Woodland JG; Horatscheck A; Soares de Melo C; Dziwornu GA; Taylor D
    Prog Med Chem; 2024; 63(1):161-234. PubMed ID: 39370241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malaria: an update on current chemotherapy.
    Visser BJ; van Vugt M; Grobusch MP
    Expert Opin Pharmacother; 2014 Oct; 15(15):2219-54. PubMed ID: 25110058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel molecular targets for antimalarial chemotherapy.
    Jana S; Paliwal J
    Int J Antimicrob Agents; 2007 Jul; 30(1):4-10. PubMed ID: 17339102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.